| http://dbpedia.org/ontology/abstract
|
Lineage Cell Therapeutics, Inc. is a clini … Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical and preclinical programs are in markets with billion dollar opportunities and include five allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, which is being developed under a worldwide collaboration with Genentech, a member of the Roche Group; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; (iii) VAC2, an allogeneic dendritic cell therapy produced from Lineage's VAC technology platform for immuno-oncology and infectious disease, currently in Phase 1 clinical development for the treatment of non-small cell lung cancer; (iv) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; and (v) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage.ue to photoreceptor dysfunction or damage.
|
| http://dbpedia.org/ontology/foundingYear
|
1990
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Regenerative_medicine +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/Carlsbad%2C_California +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Lineage_Cell_Therapeutics_Updated_Logo.jpeg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_Company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://lineagecell.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
40941727
|
| http://dbpedia.org/ontology/wikiPageLength
|
19659
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1122293228
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Stem_cells +
, http://dbpedia.org/resource/Carlsbad%2C_California +
, http://dbpedia.org/resource/California_Institute_for_Regenerative_Medicine +
, http://dbpedia.org/resource/Allogeneic +
, http://dbpedia.org/resource/Genentech +
, http://dbpedia.org/resource/Roche +
, http://dbpedia.org/resource/Category:Companies_based_in_Alameda%2C_California +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Cancer_Research_UK +
, http://dbpedia.org/resource/Category:1990_establishments_in_California +
, http://dbpedia.org/resource/Public_Company +
, http://dbpedia.org/resource/Board_of_directors +
, http://dbpedia.org/resource/Category:Cancer_organizations +
, http://dbpedia.org/resource/Category:Companies_listed_on_NYSE_American +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1990 +
, http://dbpedia.org/resource/AgeX_Therapeutics +
, http://dbpedia.org/resource/Age-related_Macular_Degeneration +
, http://dbpedia.org/resource/Regenerative_medicine +
|
| http://dbpedia.org/property/bloomberg
|
LCTX:US
|
| http://dbpedia.org/property/foundation
|
1990
|
| http://dbpedia.org/property/google
|
LCTX
|
| http://dbpedia.org/property/homepage
|
https://lineagecell.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Regenerative_medicine +
, http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Brian Culley, CEO
, Jill Howe, CFO
George A. Samuel III, General Counsel & Corporate Strategy
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Carlsbad%2C_California +
|
| http://dbpedia.org/property/logo
|
File:Lineage_Cell_Therapeutics_Updated_Logo.jpeg
|
| http://dbpedia.org/property/name
|
Lineage Cell Therapeutics
|
| http://dbpedia.org/property/reuters
|
LCTX.N
|
| http://dbpedia.org/property/secCik
|
LCTX
|
| http://dbpedia.org/property/symbol
|
LCTX
|
| http://dbpedia.org/property/tradedAs
|
AMEX:LCTX
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_Company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Finance_links +
, http://dbpedia.org/resource/Template:TASE +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://dbpedia.org/property/yahoo
|
LCTX
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_based_in_Alameda%2C_California +
, http://dbpedia.org/resource/Category:Cancer_organizations +
, http://dbpedia.org/resource/Category:Stem_cells +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_listed_on_NYSE_American +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1990 +
, http://dbpedia.org/resource/Category:1990_establishments_in_California +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Lineage_Cell_Therapeutics?oldid=1122293228&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Lineage_Cell_Therapeutics_Updated_Logo.jpeg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://lineagecell.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Lineage_Cell_Therapeutics +
|
| owl:sameAs |
http://dbpedia.org/resource/Lineage_Cell_Therapeutics +
, https://global.dbpedia.org/id/fGqx +
, http://www.wikidata.org/entity/Q16971567 +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
|
| rdfs:comment |
Lineage Cell Therapeutics, Inc. is a clini … Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer.nt an effective immune response to cancer.
|
| rdfs:label |
Lineage Cell Therapeutics
|
